DNA Diagnostics Market

Global DNA Diagnostics Market By Product Type (Instruments, Reagents, Service & Software), Application (Oncology, Infectious Disease Testing, Myogenic Disorder Diagnosis, Clinical Confirmation, Prenatal Diagnosis, Pre-implantation), Technology (PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry), End User

Report Id: KBV-1144 Publication Date: January-2017 Number of Pages: 289
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The global DNA Diagnostics Market Size is expected to reach $25,851.1 million by 2022, growing at a CAGR of 12.2% during 2016 -2022.

DNA diagnostics gained prominence due to the factors such as demand for effective treatment for chronic and infectious diseases, technological advancements in diagnostic techniques, and rapidly growing awareness about healthcare in the emerging markets. DNA diagnostics is being used in several applications due to its wide spectrum of applications such as in diagnosis of infectious diseases, oncologycancer, myogenic disorders, prenatal diagnostics, pre-implantation diagnostics, etc. DNA diagnostics product market is segmented into instruments, reagents, software and services.

Click Here For Free Insights

The various types of instruments used are PCR, microarrays, sequencer, spectrometer etc. The instruments segment is the leading segment in the global DNA diagnostics product market. The rapid technological advances has led to the development of robust methodologies such as polymerase chain reaction (PCR), microarrays, gene sequencing and others. The aforementioned DNA based diagnostic methods facilitate the detection of mutations, identification of disease causing genes, and the diagnosis of myogenic disorders. The report highlights the adoption of DNA Diagnostics, globally.

Based on the Product Types, the Global DNA Diagnostics Market is segmented into Instruments, Reagents and Service & software segment. Based on the Application, the market is bifurcated into Oncology, Infectious disease testing, Myogenic disorder diagnosis, Clinical confirmation diagnostics, Prenatal diagnosis, Pre-implantation diagnostics and other segments. Based on the Technology, the market is bifurcated into PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry and other segments. Further, the market is segmented into POC (Point-of-Care), Central Laboratories and Self-Testing segments based on the End Users. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).

Key Players profiled in the report includes Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc, Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc. and Bio-Rad Laboratories.

Related Reports-

North America DNA Diagnostics Market

Europe DNA Diagnostics Market

 Asia Pacific DNA Diagnostics Market   

LAMEA DNA Diagnostics Market

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo